SEER-Medicare Analyses
We created a summary of all of the SEER Medicare publications through 2012, which is available on the publications page of National Cancer Institute (NCI) SEER Medicare website. A direct link to the Powerpoint presentation is here.
We have also given a presentation at ISPOR 2011 on the use of inverse probability weighting to predict long-term costs of care using SEER Medicare data. The presentation can be downloaded here.
We hold ourselves to the highest academic standards in all of our research, but this is particularly true for our SEER Medicare projects. All SEER Medicare research is conducted with an unrestricted right to publish our findings, as required by the NCI. This enables us to conduct work for clients, as well as to conduct our own, self-funded research projects. Please see the following editorial for more about our SEER Medicare work. Below is a listing of our SEER Medicare publications:
Selected publications are listed below:
- Danese MD, Lindquist K, Doan J, Lalla D, Brammer M, Griffiths RI. Effect of Central Nervous System Metastases on Treatment Discontinuation and Survival in Older Women Receiving Trastuzumab for Metastatic Breast Cancer. J Cancer Epidemiol. 2012.
- Griffiths RI, Barron RL, Gleeson ML, Danese MD, O’Hagan A, Chia VM, Legg JC, Lyman GH. Granulocyte-colony stimulating factor use and medical costs after initial adjuvant chemotherapy in older patients with early-stage breast cancer. PharmacoEconomics. 2012;30(2):103-118.
- Griffiths R, Mikhael J, Gleeson M, Danese M, Dreyling M. Addition of Rituximab to Chemotherapy Alone as First-Line Therapy Improves Overall Survival in Elderly Patients with Mantle Cell Lymphoma. Blood, 2011;118(18):4808-4816.
- Griffiths RI, Lalla D, Herbert RJ, Doan JF, Brammer MG, Danese MD.Infused therapy and survival in older patients diagnosed with metastatic breast cancer who received trastuzumab. Cancer Invest. 2011 Nov;29(9):573-84.
- Lindquist, K., Danese, M. D., Mikhael, J., Knopf, K. B., Griffiths, R. I. Health Care Utilization and Mortality Among Elderly Patients With Myelodysplastic Syndromes. Ann Oncol. 2011 May;22(5):1181-8. Epub 2010 Nov 1.
- Danese MD, Griffiths RI, Gleeson M, Satram-Hoang S, Knopf K, Mikhael J, Reyes C. An observational study of outcomes after initial infused therapy in Medicare patients diagnosed with chronic lymphocytic leukemia.. Blood. 2011 Mar 31;117(13):3505-13. Epub 2010 Dec 29.
- Griffiths R, Gleeson M, Reyes C, Knopf K, Danese M. Survival in elderly follicular lymphoma patients who receive frontline chemo-immunotherapy. Am J Hematol. 2010 Dec;85(12):963-7.
- Griffiths R, Gleeson M, Knopf K, Danese M. Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL). BMC Cancer. 2010 Nov 12;10:625.
- M. Danese, C. O’Malley, D. Kim, K. Lindquist, M. Gleeson, R. Griffiths, D. Wyszynski. Comorbidities in Medicare patients with and without breast cancer. J Clin Oncol 27:15s, 2009 (suppl; abstr 6533).
- C. D. O’Malley, M. Danese, K. Lindquist, R. Griffiths, M. Gleeson, T. Einhorn, D. Wyszynski. Diabetes in elderly patients with breast cancer in the United States: An analysis of data from the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database. J Clin Oncol 27:15s, 2009 (suppl; abstr 11050).
- M. Danese, R. Griffiths, M. Gleeson, K. Knopf. Validating the Follicular Lymphoma International Prognostic Index (FLIPI) Using SEER-Medicare Claims Data. Blood (ASH Annual Meeting Abstracts) 2008 112: Abstract 872.
- Griffiths RI, Gleeson ML, Mikhael J, Danese MD. Cost and Cost-Effectiveness of Adding Rituximab to First-Line Chemotherapy for Follicular Lymphoma (FL) in Elderly Patients: An Observational Cohort Study Based on SEER-Medicare. J Cancer Epidemiol. 2012.
- Griffiths RI, Gleeson ML, Mikhael J, Dreyling M, Danese MD. Comparative Effectiveness and Cost of Adding Rituximab to First-Line Chemotherapy for Elderly Patients Diagnosed with Diffuse Large B-Cell Lymphoma. Cancer, 2012.
- Griffiths RI, Gleeson ML, Danese MD, O’Hagan A. Inverse Probability Weighted Least Squares Regression in the Analysis of Time-Censored Cost Data: An Evaluation of the Approach Using SEER-Medicare. Value Health. 2012 Jul;15(5):656-63. Epub 2012 Jun 22.
- Griffiths RI, O’Malley CD, Herbert RJ, Danese MD. Misclassification of Incident Conditions Using Claims Data: Impact of Varying the Period Used to Exclude Pre-Existing Disease. (Submitted).
- Griffiths RI, Gleeson ML, Valderas JM, Danese MD. Undiagnosed Comorbidity in Older Women with Breast Cancer: Incidence, Risk Factors, and Outcomes. (Submitted)
- Griffiths RI, Danese MD, Gleeson ML, Valderas JM. Epidemiology and Outcomes of Undiagnosed Diabetes in Older Women Diagnosed With Breast Cancer: An Observational Cohort Study Based on SEER-Medicare. (Submitted).
- Griffiths RI, Lindquist KJ, O’Malley CD, Gleeson ML, Duryea JL, Valderas JM, Danese MD. Undiagnosed Diabetes in Breast, Colorectal, Lung, and Prostate Cancer: Incidence and Risk Factors. (Submitted).